To view this email as a web page, click here.
 
CHECK OUT OUR OCTOBER ISSUE
 
Contemporary OBGYN cover
View the full issue here.
Elective induction at 39 weeks: A reasonable option
Recent studies underscore the benefits of induction at 39 weeks in healthy nulliparas but the decision to deliver should remain up to the mother.
Read more
Female health technology takes center stage
Digital transformation of the women’s health market is rapidly occurring through FemTech (female technology).
Read more
 
Did reliance on technology contribute to fetal demise?
image description here A pregnant patient in recovery from a cerclage was given oxytocin because of preset electronic orders.

Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.